Two Sigma Investments, LP Alnylam Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

  • $42.8 Billion
  • Q1 2025

A detailed history of Two Sigma Investments, LP transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 197,415 shares of ALNY stock, worth $84.9 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
197,415
Previous 107,117 84.3%
Holding current value
$84.9 Million
Previous $25.2 Million 111.49%
% of portfolio
0.12%
Previous 0.06%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025
BUY
$233.07 - $290.7 $21 Million - $26.2 Million
90,298 Added 84.3%
197,415 $53.3 Million
Q4 2024

Feb 14, 2025
BUY
$232.27 - $300.43 $20.4 Million - $26.4 Million
87,969 Added 459.42%
107,117 $25.2 Million
Q3 2024

Nov 14, 2024
SELL
$233.81 - $287.01 $19.6 Million - $24 Million
-83,770 Reduced 81.39%
19,148 $5.27 Million
Q2 2024

Aug 14, 2024
BUY
$143.31 - $247.0 $58,183 - $100,282
406 Added 0.4%
102,918 $25 Million
Q1 2024

May 15, 2024
BUY
$146.51 - $198.2 $15 Million - $20.3 Million
102,512 New
102,512 $15.3 Million
Q3 2023

Nov 14, 2023
SELL
$170.77 - $211.65 $37.8 Million - $46.9 Million
-221,369 Reduced 98.53%
3,300 $584,000
Q2 2023

Aug 14, 2023
BUY
$185.01 - $212.05 $10.6 Million - $12.2 Million
57,323 Added 34.25%
224,669 $42.7 Million
Q1 2023

May 15, 2023
SELL
$182.66 - $235.53 $2.81 Million - $3.62 Million
-15,361 Reduced 8.41%
167,346 $33.5 Million
Q4 2022

Feb 14, 2023
SELL
$185.53 - $241.31 $6.31 Million - $8.21 Million
-34,005 Reduced 15.69%
182,707 $43.4 Million
Q3 2022

Nov 14, 2022
BUY
$138.54 - $232.0 $30 Million - $50.3 Million
216,712 New
216,712 $43.4 Million
Q2 2022

Aug 15, 2022
SELL
$120.42 - $169.29 $8.9 Million - $12.5 Million
-73,949 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$127.18 - $173.91 $9.4 Million - $12.9 Million
73,949 New
73,949 $12.1 Million
Q2 2021

Aug 16, 2021
SELL
$128.63 - $176.89 $4.71 Million - $6.48 Million
-36,619 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$126.83 - $175.69 $4.64 Million - $6.43 Million
36,619 New
36,619 $5.17 Million
Q4 2018

Feb 14, 2019
SELL
$62.67 - $88.33 $1.3 Million - $1.83 Million
-20,675 Closed
0 $0
Q3 2018

Nov 14, 2018
BUY
$87.52 - $122.67 $1.81 Million - $2.54 Million
20,675 New
20,675 $1.81 Million
Q2 2018

Aug 14, 2018
SELL
$88.31 - $107.8 $22.6 Million - $27.6 Million
-256,376 Closed
0 $0
Q1 2018

May 15, 2018
SELL
$115.92 - $148.54 $5.33 Million - $6.83 Million
-46,000 Reduced 15.21%
256,376 $30.5 Million
Q4 2017

Feb 14, 2018
BUY
$114.49 - $139.98 $18.1 Million - $22.2 Million
158,502 Added 110.17%
302,376 $38.4 Million
Q3 2017

Nov 14, 2017
BUY
$72.53 - $118.27 $10.4 Million - $17 Million
143,874
143,874 $16.9 Million

Others Institutions Holding ALNY

# of Institutions
748
Shares Held
114M
Call Options Held
851K
Put Options Held
817K
View Full List

About ALNYLAM PHARMACEUTICALS, INC.

ALNY Quotes by TradingView
  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $52.9B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Two Sigma Investments, LP Portfolio

Follow Two Sigma Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email